Facing Long Odds, Anthem Plans To Appeal Cigna Merger Decision
Meanwhile, the $1.85 billion breakup fee is likely to cause further tension between the two companies.
The independent source for health policy research, polling, and news.
34,501 - 34,520 of 112,520 Results
Meanwhile, the $1.85 billion breakup fee is likely to cause further tension between the two companies.
As a result of the many delays, the government is still covering prescriptions written by doctors who have been kicked out of Medicare and even some who have pleaded guilty to crimes.
House committees weigh measures that would restructure Medicaid eligibility and would transform the program into a block grant system that would give states more control and perhaps less funding. But some Republican senators from states that have expanded Medicaid under the health law held a meeting this week to discuss their views about possible changes. News reports also look at Medicaid developments in Kansas and Missouri.
Hundreds are turning out to town hall meetings -- taking a page from Republicans' playbook when the Affordable Care Act was passed -- to get answers on the future of the health law.
The state chose not to expand Medicaid and has been struggling for years to come up with a system that makes sure people have access to affordable health care. Meanwhile, a new study examines why the Affordable Care Act succeeded in some states and not others.
The report, which did not take into account any replacement efforts, found California would have the highest number of job losses at 334,000, followed by Florida at 181,000, Texas at 175,000, then Pennsylvania with 137,000. In other news, some doctors organizations are staying quiet on repeal plans for now, and insurers are struggling with the uncertainty surrounding their industry at the moment.
Initial enrollment is about 4 percent lower than last year, but it still illustrates the risk Republicans face as they begin moving to dismantle the law. Media outlets report on news out of Minnesota and California as well.
Rep. Tom Price, R-Ga., drew scrutiny from Democrats about both his health care views and his stock trading.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Opinion writers offer their takes on what Republican lawmakers might do with Obamacare and the challenges it will involve.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Outlets report on news from Connecticut, Wisconsin, Arizona, Ohio, Massachusetts, New Hampshire, Michigan, Pennsylvania, Maryland, Florida, Texas and California.
Lawmakers in Kansas are also considering a requirement that women seeking an abortion receive details about the provider's medical credentials, malpractice insurance and past disciplinary action. Meanwhile, Planned Parenthood endorses a California assemblyman.
Though doctors have always told patients to keep taking their antibiotics even when they feel better, those recommendations may be completely wrong. Meanwhile, NPR takes a look at how we got to the golden age of germs. In other public health news: health crises, licorice during pregnancy, concussions, the flu, bullying and more.
“Such a steep rise in the cost of this drug threatens to price-out families and communities that depend on naloxone to save lives,” the senators wrote to the drugmaker.
In other pharmaceutical industry news, Gilead Sciences' revenue problem, a status check of Food and Drug Administration user fees and Vice President Mike Pence's position on right-to-try laws.
Dozens of agencies that provide services to Medicaid enrollees with disabilities will be affected by the cuts announced by AmeriHealth Caritas, which is the largest of the three firms hired by the state to handle the Medicaid program. Managed care programs in Tennessee and California are also in the news.
The BRIDGE Act would allow undocumented immigrants who meet DACA requirements to apply for protection from deportation and for work authorization for three years.
The ruling echoes an earlier case that rejected the proposed Aetna-Humana megamerger.
© 2026 KFF